Page last updated: 2024-09-04

tariquidar and Granulocytic Leukemia

tariquidar has been researched along with Granulocytic Leukemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Alexiou, P; Chilov, GG; Ivanova, ES; Novikov, FN; Pelecanou, M; Sagnou, M; Shtil, AA; Stroylov, VS; Tatarskiy, VV; Titov, IY; Vagida, MS	1

Other Studies

1 other study(ies) available for tariquidar and Granulocytic Leukemia

Article	Year
Novel curcumin derivatives as P-glycoprotein inhibitors: Molecular modeling, synthesis and sensitization of multidrug resistant cells to doxorubicin. European journal of medicinal chemistry, 2020, Jul-15, Volume: 198 Topics: Amides; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Cell Survival; Curcumin; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; K562 Cells; Leukemia, Myeloid; Models, Molecular; Structure-Activity Relationship	2020

Article

Year

Novel curcumin derivatives as P-glycoprotein inhibitors: Molecular modeling, synthesis and sensitization of multidrug resistant cells to doxorubicin.

European journal of medicinal chemistry, 2020, Jul-15, Volume: 198

Topics: Amides; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Cell Survival; Curcumin; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; K562 Cells; Leukemia, Myeloid; Models, Molecular; Structure-Activity Relationship

2020